Download PDF Introduction 2025 began with cautious optimism about an uptick in M&A over the course of the year, however, it was challenged by higher than expected uncertainty around trade policies, geopolitical tensions and economic growth. Global M&A volumes declined by 9% in H1 2025 compared to H1 2024, while Read more…
Download PDF Introduction In 2024, over 240 activist campaigns were launched globally, the highest number since 2018, according to a Barclays report. The US and APAC remained the primary regions for activism, with 44% and 29% of campaigns initiated in these areas, respectively. Meanwhile, activity in Europe saw a slight Read more…
Download PDF Introduction In 2024, global M&A activity maintained a strong pace, with deal value rising by approximately 15% compared to 2023. This growth occurred despite market conditions improving less than expected, as interest rates remained high and geopolitical tensions persisted worldwide. The trend continued in the final months of Read more…
Download PDF Introduction The Consumer Healthcare sector has long been crucial for consumers to find quick solutions without heading to the doctors, covering over the counter (OTC) products such as supplements, medicines (painkillers), skincare, hygiene products, and more. With the rise of digital healthcare tools and prescription management, Consumer Healthcare Read more…
Download PDF Introduction When underwriting any debt investment, two fundamental questions must be asked: will the borrower be able to repay us? And if not, can we enforce claims over the debtor’s assets? In this article we will be discussing the increased aggression of claim enforcement- not on the company- Read more…
Download PDF Johnson & Johnson and its Competitors Johnson & Johnson (J&J) [NYSE: JNJ] is a US-based multinational healthcare corporation operating along its two segments Innovative Medicine and MedTech. Today (as of April 18th, 2024), the firm has a market capitalization of $351.2bn. In 2023, J&J recorded revenues of $85.2bn, Read more…
Download PDF Introduction Several factors, including high inflation, high interest rates, and overall uncertainty in the market, resulted in a decline in M&A activity in 2023. Despite the rough year, Q4 2023 and the first two months of 2024 have shown that deal activity is due for a comeback. One Read more…
Download PDF Introduction The landscape of weight loss medication is currently undergoing a significant transformation with the emergence of highly effective new drugs. These innovative pharmaceuticals are designed to aid individuals dealing with obesity in shedding substantial body weight, and their performance in clinical trials is exceptionally promising. A notable Read more…
Download PDF Introduction On October 3rd, pharmaceutical giant Eli Lilly and Company [LLY:NYSE] announced its plans to strengthen its collection of cancer drugs through the acquisition of POINT Biopharma [PNT:NASDAQ] for $1.4bn, representing a premium of almost 90%. The firm’s purchase of POINT, a clinical-stage radiopharmaceutical company with a focus Read more…
Download PDF Introduction The healthcare industry saw a surge in M&A activity post-pandemic in 2021 which stretched across geographies and was driven by an incentive to consolidate healthcare systems to exploit economies of scale, fill pipelines, and boost top-line growth. In 2022, macroeconomic conditions, namely uncertainty, inflation, and high labour Read more…
Download PDF Introduction This week Merck & Co. announced one of the biggest healthcare deals disclosed so far in 2023. The US drug maker reached an agreement with Prometheus Biosciences to acquire the company in an all-cash transaction that values Prometheus at $10.8bn, a 75% premium to its market cap Read more…
Download PDF Introduction CVS Health has agreed to buy Oak Street Health in a $10.6bn deal, to further integrate primary care into the healthcare conglomerate, through the acquisition of the Medicare-focused company. According to CVS management statements, the deal is expected to close by the end of this year and will be Read more…
Download PDF Introduction On October 31st, Thermo Fisher Scientific [TMO: NYSE], one of the global leaders in the supply of scientific instrumentation, announced that it had entered a definitive agreement to acquire The Binding Site Group, a Birmingham-based specialty diagnostics firm. European private equity firms Nordic Capital and Five Arrow Read more…
Download PDF Introduction On November 1 Johnson & Johnson, an American multinational which develops medical devices and is ranked 36 in the fortune 500 companies with yearly sales of $98.3bn, announced its proposal to acquire AbioMmed [ABMD: NASDAQ], a cardiovascular technology group. The acquisition, worth $16.6bn, will make Johnson & Read more…
Download PDF Introduction On March 29, 2022, UnitedHealth Group Inc. announced it would acquire LHC Group Inc. for $5.4bn. The deal is expected to close in the second half of 2022, pending shareholders’ approvals and regulatory approvals. This deal comes immediately after UnitedHealth’s $13bn acquisition of Change Healthcare which the Read more…